{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:19:46Z","timestamp":1789064386605,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04214-9","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T03:35:23Z","timestamp":1776051323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential expression of estrogen and progesterone receptors before and after surgery in endometrial cancer and analysis of recurrence prediction model"],"prefix":"10.1186","volume":"24","author":[{"given":"Ruixue","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"10023","key":"4214_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"PLA Morice","year":"2016","unstructured":"Morice PLA, Creutzberg C, et al. Endometrial cancer. Lancet Oncol. 2016;387(10023):1094\u2013108.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4214_CR2","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, MKD, Fuchs HE, et al. Cancer statistics. CA Cancer J. 2022;72(1):7\u201333.","journal-title":"CA Cancer J"},{"key":"4214_CR3","doi-asserted-by":"crossref","unstructured":"Sohaib SA, HSL, Meroni R et al. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol. 2007;62(1): 28\u201334:discussion 35\u201326.","DOI":"10.1016\/j.crad.2006.06.015"},{"issue":"9213","key":"4214_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355(9213):1404\u201311.","journal-title":"Lancet"},{"issue":"3","key":"4214_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol. 2004;92(3):744\u201351.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4214_CR6","first-page":"179","volume":"5","author":"A Huijgens","year":"2013","unstructured":"Huijgens A, N MHJ. Factors predicting recurrent endometrial cancer. Facts Views Vis Obgyn. 2013;5(3):179\u201386.","journal-title":"Facts Views Vis Obgyn"},{"issue":"1","key":"4214_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","volume":"13","author":"V Kurra","year":"2013","unstructured":"Kurra V, Krajewski KM, Jagannathan J, Giardino A, Berlin S, Ramaiya N. Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging. 2013;13(1):113\u201322.","journal-title":"Cancer Imaging"},{"issue":"1","key":"4214_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3802\/jgo.2011.22.1.3","volume":"22","author":"TWH Odagiri","year":"2011","unstructured":"Odagiri TWH, Hosaka M, et al. Multivariate survival analysis of the patientswith recurrent endometrial cancer. J Gynecol Oncol. 2011;22(1):3\u20138.","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"4214_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1097\/IGC.0000000000001304","volume":"28","author":"VMB Lago","year":"2018","unstructured":"Lago VMB, Ballesteros E, et al. Tumor grade correlation between preoperative biopsy and final surgical specimen in endometrial cancer: the use of different diagnostic methods and analysis of associated factors. Int J Gynecol Cancer. 2018;28(7):1258\u201363.","journal-title":"Int J Gynecol Cancer"},{"key":"4214_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s10147-019-01437-7","volume":"24","author":"M De Francesca","year":"2019","unstructured":"De Francesca M, Vincenzo, Tombolini, et al. Immune check\u2013point in endometrial cancer. Int J Clin Oncol. 2019;24:910\u20136.","journal-title":"Int J Clin Oncol"},{"key":"4214_CR11","doi-asserted-by":"publisher","first-page":"e473114","DOI":"10.1200\/EDBK-25-473114","volume":"45","author":"N Kathleen","year":"2025","unstructured":"Kathleen N, Moore M, Joyce MS, Liu F, MD, MPH; and, Lorusso D. MD, PhD. State of the art: therapies now and around the corner for gynecologic cancers. Am Soc Clin Oncol Educational Book. 2025;45:e473114.","journal-title":"Am Soc Clin Oncol Educational Book"},{"issue":"2","key":"4214_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ygyno.2020.05.012","volume":"158","author":"ADAMC Di Spiezio Sardo","year":"2020","unstructured":"Di Spiezio Sardo ADAMC, Della Corte L, et al. Should endometrial biopsy under direct hysteroscopic visualization using the Grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer? Gynecol Oncol. 2020;158(2):347\u201353.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4214_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"ISAT Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack ISAT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"4214_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ygyno.2022.08.016","volume":"167","author":"SW Vrede","year":"2022","unstructured":"Vrede SW, HAMC, Reijnen C, et al. The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification. Gynecol Oncol. 2022;167(2):196\u2013204.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4214_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ygyno.2017.11.027","volume":"148","author":"D Smith","year":"2018","unstructured":"Smith D, Stewart CJR, Clarke EM, Lose F, Davies C, Armes J, et al. ER and PR expression and survival after endometrial cancer. Gynecol Oncol. 2018;148(2):258\u201366.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"4214_CR16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.7150\/jca.41943","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Tran DA, Fu MZ, Chen W, Fu SW, Li X. Estrogen receptor, progesterone receptor, and HER2 receptor markers in endometrial cancer. J Cancer. 2020;11(7):1693\u2013701.","journal-title":"J Cancer"},{"issue":"1","key":"4214_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","volume":"26","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and Follow-up. Int J Gynecol Cancer. 2016;26(1):2\u201330.","journal-title":"Int J Gynecol Cancer"},{"key":"4214_CR18","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.2147\/JIR.S362166","volume":"15","author":"PWJ Jiang","year":"2022","unstructured":"Jiang PWJ, Gong C, et al. A nomogram model for predicting recurrence of stage I-III endometrial cancer based on Inflammation-Immunity-Nutrition score (IINS) and traditional classical predictors. J Inflamm Res. 2022;15:3021\u201337.","journal-title":"J Inflamm Res"},{"key":"4214_CR19","doi-asserted-by":"publisher","first-page":"586081","DOI":"10.3389\/fonc.2020.586081","volume":"10","author":"PJM Jiang","year":"2020","unstructured":"Jiang PJM, Hu J, et al. A nomogram model involving immunohistochemical markers for predicting the recurrence of stage I-II endometrial cancer. Front Oncol. 2020;10:586081.","journal-title":"Front Oncol"},{"key":"4214_CR20","first-page":"3021","volume":"15","author":"PWJ Jiang","year":"2022","unstructured":"Jiang PWJ, Gong C, et al. Analysis of factors related to lymph node metastasis in Early-Stage type 1 endometrial cancer: verifying the clinical value of positive threshold of the immunohistochemical parameter Ki67. Cancer Manag Res. 2022;15:3021\u201337.","journal-title":"Cancer Manag Res"},{"issue":"31","key":"4214_CR21","doi-asserted-by":"publisher","first-page":"49289","DOI":"10.18632\/oncotarget.10334","volume":"7","author":"ILOTB Tangen","year":"2016","unstructured":"Tangen ILOTB, Kopperud R, et al. Androgen receptor as potential therapeutic target in metastatic endometrial cancer. Oncotarget. 2016;7(31):49289\u201398.","journal-title":"Oncotarget"},{"issue":"4","key":"4214_CR22","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.3802\/jgo.2021.32.e48","volume":"32","author":"M Daix","year":"2021","unstructured":"Daix M, Angeles MA, Migliorelli F, Kakkos A, Martinez Gomez C, Delbecque K, et al. Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer. J Gynecol Oncol. 2021;32(4):e48.","journal-title":"J Gynecol Oncol"},{"issue":"12","key":"4214_CR23","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.21037\/tcr-20-2228","volume":"9","author":"D Lukanovic","year":"2020","unstructured":"Lukanovic D, Matjasic M, Kobal B. Accuracy of preoperative sampling diagnosis for predicting final pathology in patients with endometrial carcinoma: a review. Transl Cancer Res. 2020;9(12):7785\u201396.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"4214_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","volume":"16","author":"EF Schisterman","year":"2005","unstructured":"Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16(1):73\u201381.","journal-title":"Epidemiology"},{"issue":"5","key":"4214_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/13697137.2023.2205581","volume":"26","author":"SG Vitale","year":"2023","unstructured":"Vitale SG, Moore O, Riemma G, Carugno J, Yarto ML, Haimovich S. Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study. Climacteric. 2023;26(5):497\u2013502.","journal-title":"Climacteric"},{"key":"4214_CR26","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2147\/IJWH.S530879","volume":"17","author":"J Li","year":"2025","unstructured":"Li J, Yang L, Wang Y, He M, Zhu H, Huang Y. Hysteroscopic myomectomy for type 2 submucosal Myoma pretreated by HIFU and mifepristone treatment: A case report and literature review. Int J Womens Health. 2025;17:2401\u201312.","journal-title":"Int J Womens Health"},{"issue":"5","key":"4214_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/13697137.2024.2376189","volume":"27","author":"SG Vitale","year":"2024","unstructured":"Vitale SG, Angioni S, D\u2019Alterio MN, Ronsini C, Saponara S, De Franciscis P, et al. Risk of endometrial malignancy in women treated for breast cancer: the BLUSH prediction model - evidence from a comprehensive multicentric retrospective cohort study. Climacteric. 2024;27(5):482\u20138.","journal-title":"Climacteric"},{"key":"4214_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.maturitas.2019.01.017","volume":"123","author":"M Dueholm","year":"2019","unstructured":"Dueholm M, Hjorth IMD, Dahl K, Pedersen LK, Ortoft G. Identification of endometrial cancers and atypical hyperplasia: development and validation of a simplified system for ultrasound scoring of endometrial pattern. Maturitas. 2019;123:15\u201324.","journal-title":"Maturitas"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04214-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:05:01Z","timestamp":1779159901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04214-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4214"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04214-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7441185\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the First Affiliated Hospital of Chongqing Medical University (IRB Nos. 2021\u2009\u2212\u2009676 and 2023-002). All data were collected from pre-existing clinical records. The IRB waived the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}